CLAG-GO for Patients With Persistent, Relapsed or Refractory AML

Clinical trial NCT04050280 · RECRUITING

Trial details

NCT number: NCT04050280
Sponsor: University of Maryland, Baltimore
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia, Adult Acute Myeloid Leukemia Recurrent Acute Myeloid Leukemia, Relapsed, Adult

Start date: 2019-11-01
Primary completion: 2027-06-30
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.